Niall O'Donnell - 16 Feb 2023 Form 4 Insider Report for SPRUCE BIOSCIENCES, INC. (SPRB)

Role
Director
Signature
/s/ Samir Gharib, Attorney-in-Fact
Issuer symbol
SPRB
Transactions as of
16 Feb 2023
Net transactions value
+$1,998,368
Form type
4
Filing time
16 May 2023, 16:08:52 UTC
Previous filing
15 Nov 2022
Next filing
10 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRB Common Stock Purchase $1,998,368 +630,400 +91% $3.17 1,326,305 16 Feb 2023 By RiverVest Venture Fund IV, L.P. F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPRB Common Stock Warrant (Right to Buy) Purchase +472,800 472,800 16 Feb 2023 Common Stock 472,800 $3.96 By RiverVest Venture Fund IV, L.P. F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in the Issuer's private offering.
F2 Represents the combined purchase price of $3.17 for Common Stock and Warrants acquired from Issuer in a private offering.
F3 RiverVest Venture Partners IV, L.P. is the general partner of RiverVest Venture Fund IV, L.P. The Reporting Person is a manager of RiverVest Venture Partners IV, LLC, the sole general partner of RiverVest Venture Partners IV, L.P., and as a result may be deemed to share dispositive voting and investment power with respect to the shares held by RiverVest Venture Partners IV, L.P. The Reporting Person disclaims beneficial ownership of all shares held by RiverVest Venture Partners IV, L.P. except to the extent of his pecuniary interests therein.
F4 The warrant was purchased in the Issuer's private offering.